Easy administration and wider patient compliance are responsible for the growth of the oral solid dosage pharmaceutical formulation market. Moreover, lesser cost associated with the production and dispersion of these formulations makes them viable for the patients.
The low- and middle-income countries are getting benefited due to these advantages provided by the pharmaceutical tablets and capsules.
The companies operating in the oral solid dosage pharmaceutical formulation market are considering new designs and formulations for widening the consumer base. They are also checking the feedbacks given by the consumers at periodic intervals to mitigate the side-effects and come up with better formulations in this regard.
The solid dosage form of medicine is amongst the most practical ways of getting the precise dose for various chronic and acute disorders. It is also a cost-effective and simple method to devise medications for the drug manufacturers. This factor has raised the popularity quotient of tablet and capsule formulation.
Oral solid dosage pharmaceutical formulations have been reported to benefit the patients such that they need not worry about measuring of doses with this kind of oral administration. Such dosage formulations come in various flavors and shapes to enhance patient compliance, which principally boosts the oral solid dosage pharmaceutical formulation market revenue.
Tablets hold the largest share of pharmaceutical solid dosage forms as they contain a higher dose of the active substance as compared to capsules. Drug manufacturers also sugarcoat certain tablets in order to mask the bitterness associated with the taste of ingredients.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
As per the National Institutes of Health (NIH), oral routes of administration, along with once-daily intake of medicines are amongst the most preferred ones. It further states that this is attributed to lower cost of medication, especially in the rural areas.
Oral solid dosage pharmaceutical formulations also help the healthcare personnel in facilitating an improved acceptance of dosage forms (DF) for patients. The NIH states that 73% of medications undergo oral route of administration, followed by parenteral and topical ones.
Oral solid dosage pharmaceutical formulations are also easy to store and keep a track, especially while administering the same to the geriatric population due to the convenience factor involved.
Raised patient compliance quotient is thus accelerating the oral solid dosage pharmaceutical formulation market growth.
Oral solid dosage pharmaceuticals are amongst the convenient dosage forms with exceptional bioavailability. Certain oral solid dosage forms like chewable tablets are turning out to be popular at a higher pace as they are user-friendly and convenient alternatives to the conventional ones. The other advantages include easy ingestion, less pain, and various types of drugs available.
Non-invasiveness, patient compliance, and ease of drug administration are the factors making oral dosage one of the preferred dosage forms. It is generally recommended in conditions where drug should be administered repeatedly and for long. It is also looked upon as a safe form of dosage apart from affordability and convenience.
Moreover, tailored dosage and drug delivery forms with prolonged release increase bioavailability of the medications and reduce need for repeated administration of medication.
The factors mentioned above are thus expanding the oral solid dosage pharmaceutical formulation market size.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest oral solid dosage pharmaceutical formulation market analysis, North America led the solid oral dosage forms landscape in 2023 and the status quo is expected to remain unchanged during the forecast period. This is attributed to speedy approvals by the U.S. FDA.
For instance, the regulatory body authorized 48 novel medicines in 2019, out of which 54% were newly approved medications, especially the oral solid dosage products. 19 of them were in the form of pills, whereas 7 as capsules.
Europe’s significant oral solid dosage pharmaceutical formulation market share is ascribed to heart disease being one amongst the leading causes of fatalities in Germany. The oral solid dosages are commonly used to treat heart diseases with Lotensin - benazepril (Rx) to manage blood pressure. As per the WHO, circulatory diseases constituted 37% of all fatalities in Germany in 2019.
The key participants in oral solid dosage pharmaceutical formulation and research institutes are engaged in drug discovery process in order to expand market for oral solid dosage pharmaceuticals.
For instance, Assembly Biosciences sponsored ‘A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABI-H3733 in Healthy Adults’ for chronic Hepatitis B. As of January 2021, this was pertaining to phase 1 of the clinical trials.
Key participants are also launching new products to sustain themselves. For instance, in November 2023, Stratasys launched the F3300 Fused Deposition Modelling (FDM) 3D printing technology, which has quicker extrusion, gantry speeds, and auto-calibration.
AstraZeneca plc, Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Biogen Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Amgen Inc., Takeda Pharmaceutical Company, and Otsuka Pharmaceutical Co., Ltd. are some of the key players spanning the oral solid dosage pharmaceutical formulation market report scope.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 654.6 Mn |
| Market Forecast (Value) in 2034 | US$ 1.1 Bn |
| Growth Rate (CAGR) | 5.2% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Mn/Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 654.6 Mn in 2023
It is projected to grow at a CAGR of 5.2% from 2024 to 2034
Improved patient compliance and ease of administration
Hospital pharmacies segment accounted for the largest share in 2023
North America was the dominant region in 2023
AstraZeneca plc, Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Biogen Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Amgen Inc., Takeda Pharmaceutical Company, and Otsuka Pharmaceutical Co., Ltd.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Oral Solid Dosage Pharmaceutical Formulation Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast, by Dosage Form
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Dosage Form, 2020-2034
6.3.1. Tablets
6.3.1.1. Conventional/Immediate Release
6.3.1.2. Modified Release
6.3.1.3. Chewable Tablets
6.3.1.4. Effervescent Tablets
6.3.2. Capsules
6.3.2.1. Hard Gelatin Capsules
6.3.2.2. Soft Gelatin Capsules
6.3.3. Powders
6.3.4. Lozenges & Pastilles
6.3.5. Gummies
6.4. Market Attractiveness Analysis, by Dosage Form
7. Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast, by Drug Release Mechanism
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Drug Release Mechanism, 2020-2034
7.3.1. Immediate Release
7.3.2. Delayed Release
7.3.3. Controlled Release
7.4. Market Attractiveness Analysis, by Drug Release Mechanism
8. Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Distribution Channel, 2020-2034
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness Analysis, by Distribution Channel
9. Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Dosage Form, 2020-2034
10.3.1. Tablets
10.3.1.1. Conventional/Immediate Release
10.3.1.2. Modified Release
10.3.1.3. Chewable Tablets
10.3.1.4. Effervescent Tablets
10.3.2. Capsules
10.3.2.1. Hard Gelatin Capsules
10.3.2.2. Soft Gelatin Capsules
10.3.3. Powders
10.3.4. Lozenges & Pastilles
10.3.5. Gummies
10.4. Market Value Forecast, by Drug Release Mechanism, 2020-2034
10.4.1. Immediate Release
10.4.2. Delayed Release
10.4.3. Controlled Release
10.5. Market Value Forecast, by Distribution Channel, 2020-2034
10.5.1. Hospital Pharmacies
10.5.2. Retail Pharmacies
10.5.3. Online Pharmacies
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Dosage Form
10.7.2. By Drug Release Mechanism
10.7.3. By Distribution Channel
10.7.4. By Country
11. Europe Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Dosage Form, 2020-2034
11.3.1. Tablets
11.3.1.1. Conventional/Immediate Release
11.3.1.2. Modified Release
11.3.1.3. Chewable Tablets
11.3.1.4. Effervescent Tablets
11.3.2. Capsules
11.3.2.1. Hard Gelatin Capsules
11.3.2.2. Soft Gelatin Capsules
11.3.3. Powders
11.3.4. Lozenges & Pastilles
11.3.5. Gummies
11.4. Market Value Forecast, by Drug Release Mechanism, 2020-2034
11.4.1. Immediate Release
11.4.2. Delayed Release
11.4.3. Controlled Release
11.5. Market Value Forecast, by Distribution Channel, 2020-2034
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Pharmacies
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Dosage Form
11.7.2. By Drug Release Mechanism
11.7.3. By Distribution Channel
11.7.4. By Country/Sub-region
12. Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Dosage Form, 2020-2034
12.3.1. Tablets
12.3.1.1. Conventional/Immediate Release
12.3.1.2. Modified Release
12.3.1.3. Chewable Tablets
12.3.1.4. Effervescent Tablets
12.3.2. Capsules
12.3.2.1. Hard Gelatin Capsules
12.3.2.2. Soft Gelatin Capsules
12.3.3. Powders
12.3.4. Lozenges & Pastilles
12.3.5. Gummies
12.4. Market Value Forecast, by Drug Release Mechanism, 2020-2034
12.4.1. Immediate Release
12.4.2. Delayed Release
12.4.3. Controlled Release
12.5. Market Value Forecast, by Distribution Channel, 2020-2034
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Pharmacies
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Dosage Form
12.7.2. By Drug Release Mechanism
12.7.3. By Distribution Channel
12.7.4. By Country/Sub-region
13. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Dosage Form, 2020-2034
13.3.1. Tablets
13.3.1.1. Conventional/Immediate Release
13.3.1.2. Modified Release
13.3.1.3. Chewable Tablets
13.3.1.4. Effervescent Tablets
13.3.2. Capsules
13.3.2.1. Hard Gelatin Capsules
13.3.2.2. Soft Gelatin Capsules
13.3.3. Powders
13.3.4. Lozenges & Pastilles
13.3.5. Gummies
13.4. Market Value Forecast, by Drug Release Mechanism, 2020-2034
13.4.1. Immediate Release
13.4.2. Delayed Release
13.4.3. Controlled Release
13.5. Market Value Forecast, by Distribution Channel, 2020-2034
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Pharmacies
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Dosage Form
13.7.2. By Drug Release Mechanism
13.7.3. By Distribution Channel
13.7.4. By Country/Sub-region
14. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Dosage Form, 2020-2034
14.3.1. Tablets
14.3.1.1. Conventional/Immediate Release
14.3.1.2. Modified Release
14.3.1.3. Chewable Tablets
14.3.1.4. Effervescent Tablets
14.3.2. Capsules
14.3.2.1. Hard Gelatin Capsules
14.3.2.2. Soft Gelatin Capsules
14.3.3. Powders
14.3.4. Lozenges & Pastilles
14.3.5. Gummies
14.4. Market Value Forecast, by Drug Release Mechanism, 2020-2034
14.4.1. Immediate Release
14.4.2. Delayed Release
14.4.3. Controlled Release
14.5. Market Value Forecast, by Distribution Channel, 2020-2034
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Pharmacies
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Dosage Form
14.7.2. By Drug Release Mechanism
14.7.3. By Distribution Channel
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. AstraZeneca plc
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Bristol-Myers Squibb Company
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Eli Lilly and Company
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Gilead Sciences, Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Merck & Co. Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Novartis AG
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Pfizer Inc.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. AbbVie Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Boehringer Ingelheim GmbH
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. F. Hoffmann-La Roche Ltd.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Johnson & Johnson
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. Biogen Inc.
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
15.3.13. Bayer AG
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Financial Overview
15.3.13.5. Strategic Overview
15.3.14. Teva Pharmaceutical Industries Ltd.
15.3.14.1. Company Overview
15.3.14.2. Product Portfolio
15.3.14.3. SWOT Analysis
15.3.14.4. Financial Overview
15.3.14.5. Strategic Overview
15.3.15. Amgen Inc.
15.3.15.1. Company Overview
15.3.15.2. Product Portfolio
15.3.15.3. SWOT Analysis
15.3.15.4. Financial Overview
15.3.15.5. Strategic Overview
15.3.16. Takeda Pharmaceutical Company
15.3.16.1. Company Overview
15.3.16.2. Product Portfolio
15.3.16.3. SWOT Analysis
15.3.16.4. Financial Overview
15.3.16.5. Strategic Overview
15.3.17. Otsuka Pharmaceutical Co., Ltd.
15.3.17.1. Company Overview
15.3.17.2. Product Portfolio
15.3.17.3. SWOT Analysis
15.3.17.4. Financial Overview
15.3.17.5. Strategic Overview
List of Tables
Table 01: Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Dosage Form, 2020-2034
Table 02: Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Drug Release Mechanism, 2020-2034
Table 03: Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 04: Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 05: North America Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 06: North America Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Dosage Form, 2020-2034
Table 07: North America Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Drug Release Mechanism, 2020-2034
Table 08: North America Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 09: Europe Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Dosage Form, 2020-2034
Table 11: Europe Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Drug Release Mechanism, 2020-2034
Table 12: Europe Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 13: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Dosage Form, 2020-2034
Table 15: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Drug Release Mechanism, 2020-2034
Table 16: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 17: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Dosage Form, 2020-2034
Table 19: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Drug Release Mechanism, 2020-2034
Table 20: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
Table 21: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Dosage Form, 2020-2034
Table 23: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Drug Release Mechanism, 2020-2034
Table 24: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
List of Figures
Figure 01: Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Oral Solid Dosage Pharmaceutical Formulation Market Revenue (US$ Mn), by Dosage Form, 2023
Figure 03: Global Oral Solid Dosage Pharmaceutical Formulation Market Value Share, by Dosage Form, 2023
Figure 04: Global Oral Solid Dosage Pharmaceutical Formulation Market Revenue (US$ Mn), by Drug Release Mechanism, 2023
Figure 05: Global Oral Solid Dosage Pharmaceutical Formulation Market Value Share, by Drug Release Mechanism, 2023
Figure 06: Global Oral Solid Dosage Pharmaceutical Formulation Market Revenue (US$ Mn), by Distribution Channel, 2023
Figure 07: Global Oral Solid Dosage Pharmaceutical Formulation Market Value Share, by Distribution Channel, 2023
Figure 08: Global Oral Solid Dosage Pharmaceutical Formulation Market Value Share, by Region, 2023
Figure 09: Global Oral Solid Dosage Pharmaceutical Formulation Market Value (US$ Mn) Forecast, 2020-2034
Figure 10: Global Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Dosage Form, 2023 and 2034
Figure 11: Global Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Drug Release Mechanism, 2023 and 2034
Figure 13: Global Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Drug Release Mechanism, 2024-2034
Figure 14: Global Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 15: Global Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 16: Global Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Oral Solid Dosage Pharmaceutical Formulation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Dosage Form, 2023 and 2034
Figure 22: North America Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Drug Release Mechanism, 2023 and 2034
Figure 23: North America Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 24: North America Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Drug Release Mechanism, 2024-2034
Figure 26:North America Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 27: Europe Oral Solid Dosage Pharmaceutical Formulation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Dosage Form, 2023 and 2034
Figure 31: Europe Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Drug Release Mechanism, 2023 and 2034
Figure 32: Europe Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 33: Europe Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Drug Release Mechanism, 2024-2034
Figure 35: Europe Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 36: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Dosage Form, 2023 and 2034
Figure 40: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Drug Release Mechanism, 2023 and 2034
Figure 41: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 42: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Drug Release Mechanism, 2024-2034
Figure 44: Asia Pacific Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 45: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Dosage Form, 2023 and 2034
Figure 49: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Drug Release Mechanism, 2023 and 2034
Figure 50: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 51: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Drug Release Mechanism, 2024-2034
Figure 53: Latin America Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 54: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Dosage Form, 2023 and 2034
Figure 58: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Drug Release Mechanism, 2023 and 2034
Figure 59: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 60: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Drug Release Mechanism, 2024-2034
Figure 62: Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Oral Solid Dosage Pharmaceutical Formulation Market
